Treatment outcomes of low-level viremia among adults living with HIV on dolutegravir-based first line antiretroviral therapy in Botswana

被引:0
|
作者
Bareng, Ontlametse T. [1 ,2 ]
Moyo, Sikhulile [1 ,3 ]
Mudanga, Mbatshi [4 ]
Sebina, Kagiso [4 ]
Koofhethile, Catherine [1 ,3 ]
Choga, Wonderful [1 ,2 ]
Gobe, Irene [2 ]
Motswaledi, Modisa [2 ]
Maruapula, Docas [1 ]
Moraka, Natasha [1 ,2 ]
Musonda, Rosemary [1 ]
Nkomo, Joseph [5 ]
Ramaabya, Dinah [5 ]
Chebani, Tony [5 ]
Makuruetsa, Penny [5 ]
Makhema, Joseph [1 ,3 ]
Gaseitsiwe, Simani [1 ,3 ]
机构
[1] Botswana Harvard Aids Inst, Gaborone, Botswana
[2] Univ Botswana, Fac Allied Hlth Profess, Dept Med Sci, Gaborone, Botswana
[3] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[4] BUMMHI, Gaborone, Botswana
[5] Minist Hlth, Gaborone, Botswana
来源
BMJ GLOBAL HEALTH | 2023年 / 8卷 / SUPPL_10期
关键词
D O I
10.1136/bmjgh-2023-EDC.53
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OA-770
引用
收藏
页码:A24 / A24
页数:1
相关论文
共 50 条
  • [41] Role of Proviral HIV-1 DNA Genotyping for People Living with HIV (PLWH) Who Had Low-Level Viremia While Receiving Antiretroviral Therapy
    Lv, Shiyun
    Sun, Lijun
    Li, Tongzeng
    Bai, Ruojing
    Dai, Man
    Wang, Ran
    Zhai, Yuanyi
    Hua, Wei
    Li, Aixin
    Xin, Ruolei
    Dai, Lili
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 4697 - 4706
  • [42] Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy
    Gaifer, Zied
    Boulassel, Mohamed-Rachid
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2020, 19
  • [43] Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia
    Skrivankova, Veronika Whitesell
    Huwa, Jacqueline
    Muula, Guy
    Chiwaya, Geldert D.
    Banda, Esau
    Buleya, Shameem
    Chihota, Belinda
    Chintedza, Joseph
    Bolton, Carolyn
    Tweya, Hannock
    Kalua, Thokozani
    Hossmann, Stefanie
    Kouyos, Roger
    Wandeler, Gilles
    Egger, Matthias
    Lessells, Richard J.
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [44] Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy
    Mmasa, K. N.
    Powis, K.
    Sun, S.
    Makhema, J.
    Mmalane, M.
    Kgole, S.
    Masasa, G.
    Moyo, S.
    Gerschenson, M.
    Mohammed, T.
    Legbedze, J.
    Abrams, E. J.
    Kurland, I. J.
    Geffner, M. E.
    Jao, J.
    HIV MEDICINE, 2021, 22 (08) : 715 - 722
  • [45] Association between differentiated HIV care delivery model and low-level viremia among people living with HIV in Rwanda
    Sebeza, Jackson
    Mbwana, Mariam. S.
    Ramadhani, Habib. O.
    Ally, Zuhura M.
    Lascko, Taylor
    Memiah, Peter
    Tuyishime, Simeon
    Rwibasira, Galican
    AIDS RESEARCH AND THERAPY, 2024, 21 (01):
  • [46] Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
    Chen, Guan-Jhou
    Sun, Hsin-Yun
    Cheng, Aristine
    Chuang, Yu-Chung
    Huang, Yu-Shan
    Lin, Kuan-Yin
    Huang, Yi-Chia
    Liu, Wen-Chun
    Wu, Pei-Ying
    Hung, Chien-Ching
    Chang, Shan-Chwen
    MEDICINE, 2019, 98 (26)
  • [47] Unexpected Low-Level Viremia Among HIV-Infected Ugandan Adults With Untreated Active Tuberculosis
    Srikantiah, Padmini
    Wong, Joseph K.
    Liegler, Teri
    Walusimbi, Maria
    Mayanja-Kizza, Harriet
    Kayanja, Harriet K.
    Mugerwa, Roy D.
    Charlebois, Edwin D.
    Boom, W. Henry
    Whalen, Christopher C.
    Havlir, Diane V.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (04) : 458 - 460
  • [49] The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India
    Zheng, Amy
    Kumarasamy, Nagalingeswaran
    Huang, Mingshu
    Paltiel, A. David
    Mayer, Kenneth H.
    Rewari, Bharat B.
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 (03)
  • [50] Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria
    Ndembi, Nicaise
    Murtala-Ibrahim, Fati
    Tola, Monday
    Jumare, Jibreel
    Aliyu, Ahmad
    Alabi, Peter
    Mensah, Charles
    Abimiku, Alash'le
    Quinones-Mateu, Miguel E.
    Crowell, Trevor A.
    Rhee, Soo-Yon
    Shafer, Robert W.
    Gupta, Ravindra
    Blattner, William
    Charurat, Manhattan E.
    Dakum, Patrick
    AIDS RESEARCH AND THERAPY, 2020, 17 (01)